Trading Statement
Aspen Pharmacare Holdings Limited
(Incorporated in the Republic of South Africa)
(Registration number 1985/002935/06)
Share code: APN & ISIN: ZAE000066692
("Aspen")
Trading statement
Aspen shareholders are hereby advised that diluted normalised headline earnings per
share (“DNHEPS”) from continuing operations, headline earnings per share and
earnings per share for the 12 months ended 30 June 2013 are expected to exceed those
reported in the comparative period, ended 30 June 2012, within the following ranges:
Measure Range Notes
DNHEPS from continuing operations 26% to 33% 1
Headline earnings per share 16% to 23% 2
Earnings per share 16% to 23% 3
Notes:
1. DNHEPS from continuing operations comprises diluted headline earnings per share
adjusted for specific non-trading items. DNHEPS is the primary measure used by
management to assess Aspen’s underlying financial performance.
2. The growth in headline earnings per share has been diluted by the effect of an
increase in the weighted average number of ordinary shares in issue as a
consequence of the conversion of 17.6 million preference shares into an equivalent
number of ordinary shares on 28 June 2012.
3. The growth in earnings per share has been diluted as a result of capital profits on the
disposal of discontinued businesses and products in the prior year and the effect of
an increase in the weighted average number of ordinary shares in issue as a
consequence of the conversion of 17.6 million preference shares into an equivalent
number of ordinary shares on 28 June 2012.
The financial results on which this trading announcement is based have not been
reviewed or reported on by Aspen`s external auditors.
Aspen`s audited results for the 12 months ended 30 June 2013 are scheduled to be
published on SENS on 11 September 2013.
Durban
30 August 2013
Sponsor: Investec Bank Limited
Date: 30/08/2013 01:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.